Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma
about
Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinBilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report.Uterine leiomyosarcoma with central nervous system metastasesTargeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.Antiangiogenic approach in soft-tissue sarcomas.Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.
P2860
Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Phase II Study of Temozolomide ...... e or Metastatic Leiomyosarcoma
@en
type
label
Phase II Study of Temozolomide ...... e or Metastatic Leiomyosarcoma
@en
prefLabel
Phase II Study of Temozolomide ...... e or Metastatic Leiomyosarcoma
@en
P2093
P2860
P356
P1433
P1476
Phase II Study of Temozolomide ...... e or Metastatic Leiomyosarcoma
@en
P2093
Mary Hesdorffer
Mary Louise Keohan
Michelle S Boyar
Robert N Taub
Zhezhen Jin
P2860
P304
P356
10.1155/2008/412503
P577
2008-11-16T00:00:00Z